Comment: A central discrepancy revealed in this research is the failure of Z-drugs, or specifically zolpidem, to deliver on their promise of clinical safety. Despite conventional wisdom suggesting they are a safer class, the data confirms that sedative-hypnotic users as a whole faced a significantly higher mortality risk than non-users. This human clinical data provides […]
Comment: A central issue in sleep medicine is the conflict between the risk of not sleeping, and the risk of taking sedative-hypnotics to help sleep. Most people assume medication induced sleep is better than not sleeping. This 15-year prospective data confirms that daily usage is associated with nearly three times the hazard of death compared […]
Comment: It seems logical to assume that if elevated cholesterol increases cardiovascular risk, it must damage all vascular beds equally—threatening the brain just as much as the heart. Furthermore, most assume that the extreme elevations seen in familial hypercholesterolemia (FH) must confer a universally catastrophic risk. This study proves those assumptions wrong. This research serves […]
Comment: This systematic review and meta-analysis is yet another high-level confirmation of a reality seen across decades of human clinical data: soy isoflavones do not possess the systemic estrogenic risks often attributed to them. In the hierarchy of research, human RCTs carry the most weight, and the aggregation of 42 randomized controlled trials here should […]
Comment: This was one of the earlier articles that really helped illustrate how important it is to keep the focus on absolute risk reduction to truly understand how effective an intervention is. Although this is a narrative review and has many risks of bias, other studies have borne out the concerns raised that the absolute […]
Comment: This is another in a growing group of studies showing a correlation between levothyroxine (synthetic T4) use and increased cancer risk. What makes this analysis particularly compelling is the direct comparison between treated and untreated patients with hypothyroidism. While we must respect the limitations of observational data, we must also be pragmatic: we are […]
Comment: A hazard ratio of 1.17 for all-cause mortality is a statistic that shouldn’t be ignored, but unfortunately is. It translates to 45 excess deaths for every 1,000 patients treated. But the most concerning aspect of this data is the graded relationship: the longer the exposure, the higher the risk of death. This dose-response curve […]
🍵Comment: Another study dismantling the dogma that coffee is ‘bad for you.’ On the contrary, the data here shows that ‘morning-type’ drinkers enjoy a statistically significant reduction in both all-cause and cardiovascular mortality compared to non-drinkers. These findings also introduce a vital caveat: the circadian context. The fact that heavy consumption is protective only in […]
The Wonk Debate – Audio Critique & Clinical Commentary: Synthesized Clinical Bottom Line updated 12-15-25 The relationship between iodine intake and thyroid pathology is complex, following a U-shaped curve where both deficiency and excess are detrimental. While correcting iodine deficiency is a public health priority, maintaining intake beyond “adequate” levels confers no additional clinical benefit […]
Comment: This study suggests that the ‘dangers’ of high-dose iodine are likely overstated. For the vast majority of the population the healthy thyroid handles high iodine intake with resilience. The adverse events highlighted here likely represent a failure of supporting cofactors—specifically Selenium and Iron—rather than direct toxicity. These nutrients act as the ‘safety valves’ for […]
